Markets:

Overview

News

Currencies

International

Treasuries

Bank of America (NY:BAC)

49.77 -0.08 (-0.16%)

Official Closing Price Updated: 7:00 PM EDT, May 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Bank of America

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Analyst Predicts Nvidia Stock Should Be 42% Higher ↗

Today 20:50 EDT

Nvidia is well-positioned to continue shaping the future of artificial intelligence.

Via The Motley Fool

Topics Artificial Intelligence

4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy ↗

Today 20:02 EDT

4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage...

Via MarketBeat

Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference ↗

Today 15:05 EDT

Erasca (NASDAQ:ERAS) executives said the company sees multiple potential development paths for its RAS-targeting portfolio, highlighting early clinical activity for ERAS-0015 in lung, pancreatic and...

Via MarketBeat

Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification ↗

Today 12:06 EDT

Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and...

Via MarketBeat

Denali Therapeutics Says AVLAYAH Launch Ahead of Expectations After Hunter Syndrome Approval ↗

Today 6:08 EDT

Denali Therapeutics (NASDAQ:DNLI) is seeing early commercial interest for its first approved drug, AVLAYAH, following its March 24 accelerated approval for Hunter syndrome, Chief Operating Officer and...

Via MarketBeat

CRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data Looms ↗

May 15, 2026

CRISPR Therapeutics (NASDAQ:CRSP) Chief Executive Officer Sam Kulkarni said the company is entering a “second phase” as it moves beyond the initial launch of CASGEVY and prepares for data from multiple...

Via MarketBeat

Topics Intellectual Property

Akamai Stock Is Surging on an Analyst Upgrade. It’s No Longer a Legacy Tech Company.

May 15, 2026

Akamai stock is soaring as Bank of America says the company is rapidly emerging as a major AI infrastructure player, boosting its price target to $175.

Via Barchart.com

Topics Artificial Intelligence

Why Bank of America Could Be the Best Value Among the Big Banks Right Now ↗

May 15, 2026

Bank of America is one of Warren Buffett's favorite stocks.

Via The Motley Fool

Here's What the Latest Inflation Data Could Mean for Crypto ↗

May 15, 2026

This bearish inflation report could rain on the parade when it's just getting restarted.

Via The Motley Fool

Topics Economy

CG Oncology BLA Filing on Track as Key Bladder Cancer Data Nears ↗

May 15, 2026

CG Oncology (NASDAQ:CGON) executives said the company remains on track to complete a rolling biologics license application for cretostimogene in BCG-unresponsive high-risk non-muscle invasive bladder...

Via MarketBeat

Topics Initial Public Offering

CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records ↗

May 15, 2026

CeriBell (NASDAQ:CBLL) executives said the company’s first-quarter results reflected continued momentum in both new account additions and increased usage among existing hospital customers, while...

Via MarketBeat

1 Mega-Cap Stock to Own for Decades and 2 We Turn Down

May 15, 2026

Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less roo...

Via StockStory

Biogen Conference: Lupus, Kidney Programs Take Center Stage in Immunology Push ↗

May 14, 2026

Biogen (NASDAQ:BIIB) is continuing to position immunology as a larger part of its strategy, with late-stage lupus and kidney disease programs expected to shape the company’s next phase of growth, Adam...

Via MarketBeat

Bicara Therapeutics Touts Cancer Drug Progress Ahead of 2026 Pivotal Data ↗

May 14, 2026

Bicara Therapeutics (NASDAQ:BCAX) said its lead cancer drug candidate, ficerafusp alfa, remains on track for pivotal data in head and neck cancer in mid-2026, as the company outlined its development...

Via MarketBeat

Why Nvidia (NVDA) Stock Is Trading Up Today

May 14, 2026

What Happened? Shares of leading designer of graphics chips Nvidia (NASDAQ:NVDA) jumped 3.7% in the afternoon session after a Reuters report indicated the US...

Via StockStory

Topics Artificial Intelligence

Why Nebius Group Stock Is Rocketing Higher Today ↗

May 14, 2026

In the wake of a strong earnings report, this AI stock is sailing higher.

Via The Motley Fool

Topics Artificial Intelligence

Interactive Brokers, Enova, and Encore Capital Group Shares Are Soaring, What You Need To Know

May 14, 2026

What Happened? A number of stocks jumped in the afternoon session after optimism improved supported by the U.S.-China trade summit and solid U.S. economic da...

Via StockStory

Topics Government World Trade

Most active S&P500 stocks in Thursday's session ↗

May 14, 2026

Via Chartmill

Warren Buffett Has Beaten the Market Over a 60-Year Stretch. Here Are 3 of the Billionaire's Favorite Stocks. ↗

May 14, 2026

Warren Buffett may no longer be CEO, but his favorite stocks still dominate Berkshire Hathaway's portfolio.

Via The Motley Fool

Why Bank of America Is Betting Big on ASML Stock as Trump-Xi Meet

May 14, 2026

As Trump and Xi meet in Beijing, ASML stock is expected to emerge as a key winner from any easing in U.S.-China chip tensions.

Via Barchart.com

Topics Artificial Intelligence Government World Trade

This Analyst Just Upgraded Akamai Technologies. Here's Why.

May 14, 2026

Akamai stock rallies as Bank of America raises its price target to $175. Here’s why BofA is constructive on AKAM shares for the remainder of 2026.

Via Barchart.com

Topics Artificial Intelligence

Berkshire Hathaway Has a Cash Problem Most Companies Would Love to Have ↗

May 14, 2026

The conglomerate has nearly $400 billion to spend.

Via The Motley Fool

Chime Finally Turns Profitable—But Risks Remain ↗

May 14, 2026

Chime Financial delivered its first profitable quarter as revenue growth, margin expansion, and loan growth strengthened the fintech’s future prospects.

Via MarketBeat

AeroVironment CEO Says Drone Warfare Shift Is ‘Our Moment’ as Defense Demand Builds ↗

May 14, 2026

AeroVironment (NASDAQ:AVAV) Chairman, President and CEO Wahid Nawabi said accelerating global security threats are reshaping defense priorities toward drones, loitering munitions and counter-unmanned...

Via MarketBeat

Stocks making big moves yesterday: Nvidia, Salesforce, The Trade Desk, Wayfair, and Dynatrace

May 14, 2026

Check out the companies making headlines yesterday: Nvidia (NASDAQ:NVDA): Leading designer of graphics chips Nvidia (NASDAQ:NVDA) rose by 2.7% on Wednesday a...

Via StockStory

Topics Artificial Intelligence

AI Gold Rush Goes Public - Cerebras Storms Nasdaq as Cisco Rewrites the Rulebook ↗

May 14, 2026

Via Chartmill

Topics Artificial Intelligence

Annexon Highlights Q4 Geographic Atrophy Data, GBS Filing Plans at BofA Conference ↗

May 14, 2026

Annexon (NASDAQ:ANNX) President and CEO Doug Love outlined the company’s late-stage pipeline and regulatory plans during a presentation at the Bank of America Healthcare Conference, highlighting...

Via MarketBeat

Nvidia (NVDA) Stock Is Up, What You Need To Know

May 13, 2026

What Happened? Shares of leading designer of graphics chips Nvidia (NASDAQ:NVDA) jumped 2.7% in the afternoon session after sentiment improved fueled by a co...

Via StockStory

Topics Artificial Intelligence Government

Alnylam Pharmaceuticals Backs TTR Outlook as AMVUTTRA Access, Prescriber Growth Build ↗

May 13, 2026

Alnylam Pharmaceuticals (NASDAQ:ALNY) Chief Financial Officer Jeff Poulton said the company remains confident in its TTR revenue guidance despite a slower first-quarter sequential growth rate, pointing...

Via MarketBeat

Nebius Just Soared to a New 52-Week High. Here's What to Know.

May 13, 2026

Nebius shares are rallying as the company reported blockbuster Q1 financials – and even beyond headline numbers, there are ample reasons to load up on NBIS shares today.

Via Barchart.com

Topics Artificial Intelligence Earnings

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.